簇集蛋白(CLU)多克隆抗體(生物素標(biāo)記)
Biotin-Linked Polyclonal Antibody to Clusterin (CLU)
CLU; TRPM2; KUB1; CLI; APOJ; SGP2; AAG4; APO-J; SP-40; Apolipoprotein J; Complement Lysis Inhibitor; 40,Sulfated Glycoprotein 2; Testosterone-Repressed Prostate Message 2
- 編號(hào)ULAB180Po71
- 物種Sus scrofa; Porcine (Pig，豬) 相同的名稱，不同的物種。
- 來(lái)源抗體標(biāo)記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 416 ¥ 970 ¥ 1386 ¥ 3465 ¥ 13860
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Western Blot; Sample: Porcine Serum
Primary Ab: 0.2μg/ml Biotin-Linked Polyclonal Antibody to Clusterin (CLU)
Second Ab: 0.2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)CLU的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別CLU。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Sus scrofa; Porcine (Pig，豬) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPB180Po01 | 簇集蛋白(CLU)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB180Po01 | 簇集蛋白(CLU)多克隆抗體 | WB; IHC; ICC/IF |
| ULAB180Po71 | 簇集蛋白(CLU)多克隆抗體(生物素標(biāo)記) | WB |
| UMAB180Po21 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UMAB180Po26 | 簇集蛋白(CLU)單克隆抗體 | ICC/IF |
| UMAB180Po28 | 簇集蛋白(CLU)單克隆抗體 | ICC/IF |
| UMAB180Po22 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UMAB180Po23 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UMAB180Po24 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UMAB180Po25 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UMAB180Po27 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UMAB180Po29 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC |
| UFAB180Po02 | 抗簇集蛋白(CLU)單克隆抗體 | FCM |
| USEB180Po | 簇集蛋白(CLU)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB180Po | 簇集蛋白(CLU)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSB180Po01 | 簇集蛋白(CLU)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Endocrinology | Deficiency of Clusterin Exacerbates High-Fat Diet-Induced Insulin Resistance in Male Mice [Pubmed: 24684302] |
| J Mol Neurosci. | Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. [Pubmed: 24488574] |
| PLOS ONE | Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis [Pubmed:25268271] |
| journal of immunological methods | Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients. [pubmed:28390925] |
| Journal?of?Alzheimer's?Disease | Proteomics?Analysis?of?Blood?Serums?from?Alzheimer's?Disease?Patients?Using?iTRAQ?LabelingTechnology. [pubmed:27911324] |
| Biochimica Et Biophysica Acta | Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells [pubmed:28941799] |
| World Neurosurgery | Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study [pubmed:28803177] |
| BMC Cancer | Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis [Pubmed:29386009] |
| Diabetes/metabolism research and reviews | High serum clusterin levels are correlated with premature coronary artery disease in a Chinese population [Pubmed: 30659732] |
| Cancer Cell Int | Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer [33602229] |
